# Effectivity and Safety of Combination Cream of Salicylic Acid, Aqua Posae Filiformis, Niacinamide, Lipohydroxy Acid, Procerad and Zinc PCA

> **NCT05497323** · PHASE1 · UNKNOWN · sponsor: **Dr.dr.Irma Bernadette, SpKK (K)** · enrollment: 284 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Combination Cream
- **DRUG:** Adapalene 0,1% cream

## Key facts

- **NCT ID:** NCT05497323
- **Lead sponsor:** Dr.dr.Irma Bernadette, SpKK (K)
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2022-11-15
- **Final completion:** 2023-05-01
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2023-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05497323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05497323, "Effectivity and Safety of Combination Cream of Salicylic Acid, Aqua Posae Filiformis, Niacinamide, Lipohydroxy Acid, Procerad and Zinc PCA". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05497323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*